IM Cannabis (IMCC)
(Delayed Data from NSDQ)
$0.77 USD
+0.06 (8.86%)
Updated May 16, 2024 04:00 PM ET
After-Market: $0.78 +0.01 (0.91%) 7:14 PM ET
4-Sell of 5 4
C Value A Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IMCC 0.77 +0.06(8.86%)
Will IMCC be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for IMCC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMCC
IM Cannabis Corp. (IMCC) Reports Q1 Loss, Tops Revenue Estimates
IM Cannabis (IMCC) Expands Business in Germany With New Alliance
IMCC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Warby Parker Inc. (WRBY) Q2 Earnings and Revenues Beat Estimates
Verano Holdings Corp. (VRNOF) Reports Q2 Loss, Tops Revenue Estimates
ICU Medical (ICUI) Beats Q2 Earnings Estimates
Other News for IMCC
Weed Industry Celebrates Biden's Rescheduling Move: 'Most Monumental Cannabis Reform In Half A Century'
Flora Growth Goes Back To Net Loss In Q1, Positive About 'Landmark Reform' In The US, Focuses On Europe
IM Cannabis Corp. (IMCC) Q1 2024 Earnings Call Transcript
IMCC Stock Earnings: IM Cannabis Misses EPS, Misses Revenue for Q1 2024
IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue